During the past decade, Rudolfstiftung conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rudolfstiftung" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Medical University of Vienna" with 5 trials sponsored, "Bayer" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Andromeda Biotech Ltd." with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rudolfstiftung" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Hospital Rudolfstiftung" with 2 trials as a collaborator, "Medical University of Vienna" with 2 trials as a collaborator, "Austrian Society Of Surgical Oncology" with 1 trials as a collaborator and "Barmherzige Brüder Eisenstadt" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Rudolfstiftung" are "Coronary Artery Disease" (4 trials), "Atopic Dermatitis" (3 trials), "Chronic Kidney Disease" (3 trials), "Type 2 Diabetes Mellitus" (3 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Rudolfstiftung" in a lesser frequency.

Most popular intervention types in "Rudolfstiftung" are "Drug" (21 trials), "Device" (3 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Tirzepatide" (4 trials), "Baricitinib" (3 trials), "GED-0301" (3 trials) and "DiaPep277" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rudolfstiftung" are 29 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rudolfstiftung". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Rudolfstiftung, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rudolfstiftung, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".